Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,006 | -10,811 | -69,197 | -51,294 | -35,037 |
| Depreciation Amortization | -909 | -575 | -2,639 | -1,912 | -1,039 |
| Other Working Capital | -2,629 | -3,544 | -3,413 | -4,601 | -5,428 |
| Other Operating Activity | 2,651 | -1,821 | 5,724 | 2,547 | 2,993 |
| Operating Cash Flow | $-32,893 | $-16,751 | $-69,525 | $-55,260 | $-38,511 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,206 | 10,203 | 71,244 | 55,429 | 42,606 |
| PPE Investments | N/A | N/A | -206 | -200 | -35 |
| Investing Cash Flow | $28,206 | $10,203 | $71,038 | $55,229 | $42,571 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 79 | N/A | 253 | 147 | 147 |
| Financing Cash Flow | $79 | $N/A | $253 | $147 | $147 |
| Beginning Cash Position | 12,575 | 12,575 | 10,809 | 10,809 | 10,809 |
| End Cash Position | 7,967 | 6,027 | 12,575 | 10,925 | 15,016 |
| Net Cash Flow | $-4,608 | $-6,548 | $1,766 | $116 | $4,207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,893 | -16,751 | -69,525 | -55,260 | -38,511 |
| Capital Expenditure | N/A | N/A | -206 | -200 | -35 |
| Free Cash Flow | -32,893 | -16,751 | -69,731 | -55,460 | -38,546 |